Pregnancy · Rh Disease Prevention
Anti-D — Rhesus Negative Pregnancy
Why Rh-negative mums need anti-D injections at 28 weeks and after birth: prevents haemolytic disease in future pregnancies. Also after any sensitising event (bleeding, trauma, miscarriage, procedure). cffDNA screening from 11-13 weeks can identify when anti-D isn't needed. NICE NG201.
Last reviewed 2 June 2026
Routine antenatal + sensitising-event ladder
Region
Event / indication
ACOG PB 181: single dose at 28 wk for all Rh-negative non-sensitised mothers. Some centres add second dose at 32 wk in extra-long pregnancies.
Troubleshooting + common pitfalls
- Pitfall: Giving anti-D to an already-sensitised mother.
Solution: Confirm anti-D antibody NEGATIVE on group + screen before prophylaxis. Sensitised women do not benefit (antibodies already formed) — they need MCA-PSV surveillance and possible IUT instead. - Pitfall: Skipping the post-delivery dose because the antenatal dose was given.
- Solution: Antenatal prophylaxis does NOT replace the post-delivery dose. Both are needed if the neonate is Rh-positive.
- Pitfall: Giving 300 µg without KB for a large APH at term.
Solution: ≥ 20 wk events ALWAYS need KB. A massive FMH (e.g. abruption) can exceed 30 mL and need 4–6 vials. Single standard dose may be inadequate. - Pitfall: Anti-D in known Rh-negative neonate.
Solution: Confirm cord blood Rh BEFORE the post-delivery dose. If neonate Rh-negative, anti-D is unnecessary and shouldn't be given. - Pitfall: > 72-hour window missed.
Solution: Give anti-D up to 10 days after the event — partial protection. Some studies show benefit even at 28 days. “Too late” is > 28 days, not > 72 hours. - Pitfall: Anti-D in spontaneous < 12 wk miscarriage (UK practice).
Solution: RCOG GTG 22: NOT routinely required in uncomplicated spontaneous miscarriage < 12 wk WITHOUT instrumentation. ACOG is more inclusive — check local policy. - Pitfall: Confusing weak D / Du-positive mother as needing anti-D.
Solution: Most weak D / partial D individuals don’t produce anti-D antibodies and may not need prophylaxis. RHD genotyping clarifies; haematology / transfusion medicine input. - Pitfall: Treating mother of known Rh-negative father as needing anti-D.
Solution: Genuinely Rh-negative father (confirmed homozygous) → fetus will be Rh-negative → no need for prophylaxis. Cell-free fetal DNA (cffDNA) for RHD typing is increasingly used (NICE DG25) and confirms fetal type non-invasively. - Pitfall: ECV without anti-D in Rh-negative mother.
Solution: ECV is a sensitising event — give anti-D within 72 h after the procedure regardless of success. - Pitfall: Routine antenatal dose given at 28 wk — then mother has APH at 30 wk — team thinks “already covered”.
Solution: Antenatal prophylaxis does NOT cover subsequent sensitising events. Give additional anti-D + KB for the new event. - Pitfall: Anti-D given IV instead of IM.
Solution: Most preparations are IM only (deltoid or anterolateral thigh). Some preparations are licensed IV for thrombocytopenia in ITP but not for HDFN prophylaxis. Check label. - Pitfall: Documentation gaps — missed dose detected at next pregnancy.
Solution: Always document anti-D dose, date, batch, and indication in maternal handheld notes. Antibody screen at each pregnancy booking catches missed prophylaxis.
What is anti-D and why do I need it?
Anti-D immunoglobulin is an injection given to Rh-NEGATIVE pregnant women to prevent serious complications in FUTURE pregnancies.
About 15% of women are Rh-negative. If baby is Rh-positive (likely if dad is positive), small amounts of baby’s blood can enter your bloodstream. Your immune system may make anti-D antibodies — these don’t affect THIS pregnancy but in future pregnancies attack baby’s blood cells (haemolytic disease of newborn).
Anti-D Ig prevents you making those antibodies.
How do I know if I need it?
- Booking blood tests: blood group + Rh + antibody screen.
- If Rh-negative: anti-D pathway begins.
- Checked again at 28 weeks.
- Some UK trusts: cffDNA at 11-13 weeks determines baby’s Rh.
When is anti-D given?
- Routine antenatal: at 28 weeks. UK: 1500 IU once OR 500 IU at 28 + 34 wk. US: 300 µg at 28 wk.
- Postnatal: within 72h if baby Rh-positive.
- Sensitising events: extra anti-D within 72h.
Sensitising events
Any event where baby’s blood might enter yours (after 12 weeks):
- Vaginal bleeding.
- Abdominal trauma (fall, car accident).
- Amniocentesis, CVS.
- ECV (turning breech baby).
- Miscarriage (after 12 wk).
- Ectopic pregnancy.
- Termination.
- Stillbirth.
- Antepartum haemorrhage.
- Any intrauterine procedure.
Under 12 weeks uncomplicated miscarriage WITHOUT instrumentation: anti-D not routinely needed.
Tell midwife of any event so anti-D given within 72h.
What if I don’t get anti-D when needed?
Sensitisation risk ~16% without anti-D vs <1% with. Once sensitised, can’t reverse.
Future pregnancies: anti-D antibodies cross placenta, attack baby’s red cells. Causes severe anaemia, jaundice, hydrops fetalis, possibly fetal death. Prevention is far preferable.
cffDNA / fetal Rh testing
Blood test from mum at 11-13 weeks. Detects baby’s RhD gene from placental DNA in mum’s blood.
- Baby Rh-negative: no anti-D needed.
- Baby Rh-positive: standard anti-D pathway.
- Accuracy >99% from 11-13 wk.
- Saves ~40% of women unnecessary injections.
- NHS rolling out; routine Netherlands, Denmark.
Is anti-D safe?
Yes. Extensively used since 1968.
Side effects:
- Mild injection site pain (most common).
- Mild fever.
- Rare severe allergic reaction (<1 in 10,000).
- No transmission of viruses (donated plasma pathogen-inactivated).
Safe in breastfeeding.
Partner’s blood type
If dad is confirmed Rh-NEGATIVE: baby cannot be Rh-positive — anti-D not needed. Save unnecessary injection.
Otherwise (dad Rh-positive or unknown): assume baby could be Rh-positive — anti-D given. cffDNA test alternative.
Different scenarios — anti-D
Scenario 1: First Rh-neg pregnancy, no events, 28 weeks
Routine anti-D 1500 IU (UK) or 300 µg (US). Postpartum dose if baby Rh-positive.
Scenario 2: Rh-neg + miscarriage at 14 weeks
Anti-D 1500 IU within 72h. Pregnancy after 12 wk counts as sensitising event.
Scenario 3: Rh-neg + abdominal trauma at 22 wk
Anti-D + Kleihauer-Betke to quantify bleed; extra anti-D if large feto-maternal haemorrhage.
Scenario 4: Rh-neg + dad confirmed Rh-neg
No anti-D needed. Discuss confirmation testing for peace of mind.
Scenario 5: Second pregnancy with previous anti-D, no antibodies
Same pathway again: 28 wk dose + post-delivery if baby Rh-pos.
Care guidance — anti-D
- Booking blood tests establish Rh status.
- Consider cffDNA at 11-13 wk if available.
- Routine 28 wk dose (or 28 + 34 wk).
- Postnatal dose within 72h if baby Rh-pos.
- Tell midwife of any bleeding, trauma, or procedure.
- Within 72h of sensitising event.
- Kleihauer test if ≥20 wk event.
- Safe in breastfeeding.
- Future pregnancies: same pathway.
- Confirm dad’s blood type if unknown.
Sources
- NICE NG201. Antenatal care.
- RCOG Green-top Guideline 22. The use of anti-D immunoglobulin for rhesus D prophylaxis.
- NICE DG25. High-throughput non-invasive prenatal testing for fetal RHD genotype.
- BCSH. Guidelines for the use of prophylactic anti-D immunoglobulin.
Recommended for this calculator